{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:47:58Z","timestamp":1791143278232,"version":"4.1.0"},"reference-count":49,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1104.041167","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T11:39:59Z","timestamp":1332243599000},"page":"519-525","source":"Crossref","is-referenced-by-count":180,"title":["Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases"],"prefix":"10.3201","volume":"11","author":[{"given":"Anthony S.","family":"Fauci","sequence":"first","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Touchette","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory K.","family":"Folkers","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2005,4]]},"reference":[{"key":"key-10.3201\/eid1104.041167-201203200400-R1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature02759","article-title":"The challenge of emerging and re-emerging infectious diseases.","volume":"430","author":"Morens","year":"2004","journal-title":"Nature"},{"key":"key-10.3201\/eid1104.041167-201203200400-R2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1086\/319235","article-title":"Infectious diseases: considerations for the 21st century.","volume":"32","author":"Fauci","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1104.041167-201203200400-R3","unstructured":"Institute of Medicine. Microbial threats to health: emergence, detection and response. Washington, DC: The Institute; 2003."},{"key":"key-10.3201\/eid1104.041167-201203200400-R4","unstructured":"Infectious Diseases Society of America. Bad bugs, no drugs as antibiotic discovery stagnates. A public health crisis brews. Washington, DC: The Society; 2004."},{"key":"key-10.3201\/eid1104.041167-201203200400-R5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1104.041167-201203200400-R6","unstructured":"World Health Organization. The world health report 2004\u2013changing history. Geneva: The Organization; 2004."},{"key":"key-10.3201\/eid1104.041167-201203200400-R7","unstructured":"UNAIDS. 2004 report on the global AIDS epidemic: 4th global report. [cited 2005 Feb 16]. Available from http:\/\/www.unaids.org\/bangkok2004\/report.html"},{"key":"key-10.3201\/eid1104.041167-201203200400-R8","unstructured":"Centers for Disease Control and Prevention. HIV\/AIDS surveillance report 2003. Atlanta: The Centers; 2003."},{"key":"key-10.3201\/eid1104.041167-201203200400-R9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nm0703-839","article-title":"HIV and AIDS: 20 years of science.","volume":"9","author":"Fauci","year":"2003","journal-title":"Nat Med"},{"key":"key-10.3201\/eid1104.041167-201203200400-R10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1086\/428406","article-title":"Lessons from failure\u2014preparing for future HIV-1 vaccine efficacy trials.","volume":"191","author":"Graham","year":"2005","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1104.041167-201203200400-R11","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1126\/science.1086916","article-title":"The need for a global HIV vaccine enterprise.","volume":"300","author":"Klausner","year":"2003","journal-title":"Science"},{"key":"key-10.3201\/eid1104.041167-201203200400-R12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum.","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"key-10.3201\/eid1104.041167-201203200400-R13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1126\/science.1076181","article-title":"The genome sequence of the malaria mosquito Anopheles gambiae.","volume":"298","author":"Holt","year":"2002","journal-title":"Science"},{"key":"key-10.3201\/eid1104.041167-201203200400-R14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1126\/science.1074045","article-title":"Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.","volume":"298","author":"Sidhu","year":"2002","journal-title":"Science"},{"key":"key-10.3201\/eid1104.041167-201203200400-R15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.molcel.2004.09.012","article-title":"Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents.","volume":"15","author":"Johnson","year":"2004","journal-title":"Mol Cell"},{"key":"key-10.3201\/eid1104.041167-201203200400-R16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: efficacy models for compound screening.","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"key-10.3201\/eid1104.041167-201203200400-R17","first-page":"73","article-title":"Interrupting malaria transmission by genetic manipulation of anopheline mosquitoes.","volume":"40","author":"Jacobs-Lorena","year":"2003","journal-title":"J Vector Borne Dis"},{"key":"key-10.3201\/eid1104.041167-201203200400-R18","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS,S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomized controlled trial.","volume":"364","author":"Alonso","year":"2004","journal-title":"Lancet"},{"key":"key-10.3201\/eid1104.041167-201203200400-R19","unstructured":"World Health Organization. Portfolio of malaria vaccines currently in development, October, 2004. [cited 2005 Feb 16]. Available from http:\/\/www.who.int\/vaccine_research\/documents\/en\/malaria_table.pdf"},{"key":"key-10.3201\/eid1104.041167-201203200400-R20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1472-9792(02)00080-X","article-title":"Prospects for a better vaccine against tuberculosis.","volume":"83","author":"Reed","year":"2003","journal-title":"Tuberculosis (Edinb)"},{"key":"key-10.3201\/eid1104.041167-201203200400-R21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.tube.2004.01.002","article-title":"Microarrays for Mycobacterium tuberculosis.","volume":"84","author":"Butcher","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"key":"key-10.3201\/eid1104.041167-201203200400-R22","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1128\/JCM.42.7.2913-2918.2004","article-title":"High-throughput method for detecting genomic-deletion polymorphisms.","volume":"42","author":"Goguet de la Salmoniere","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1104.041167-201203200400-R23","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein.","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"key":"key-10.3201\/eid1104.041167-201203200400-R24","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis.","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid1104.041167-201203200400-R25","unstructured":"National Institute of Allergy and Infectious Diseases. Tuberculosis: ancient enemy, present threat. [cited 2005 Feb 16]. Available from http:\/\/www2.niaid.nih.gov\/newsroom\/focuson\/tb02\/tb.htm"},{"key":"key-10.3201\/eid1104.041167-201203200400-R26","unstructured":"Centers for Disease Control and Prevention. Influenza Web page. Available from http:\/\/www.cdc.gov\/flu\/"},{"key":"key-10.3201\/eid1104.041167-201203200400-R27","unstructured":"World Health Organization. Influenza Web page. [cited 2005 Feb 16]. Available from http:\/\/www.who.int\/topics\/influenza\/en\/"},{"key":"key-10.3201\/eid1104.041167-201203200400-R28","unstructured":"National Institute of Allergy and Infectious Diseases. Press releases, May 27, 2004 and August 17, 2004. [cited 2005 Feb 16]. Available from http:\/\/www2.niaid.nih.gov\/Newsroom\/Releases\/news.htm?year=2004"},{"key":"key-10.3201\/eid1104.041167-201203200400-R29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(04)15892-3","article-title":"Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.","volume":"363","author":"Webby","year":"2004","journal-title":"Lancet"},{"key":"key-10.3201\/eid1104.041167-201203200400-R30","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1126\/science.1062882","article-title":"Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.","volume":"293","author":"Hatta","year":"2001","journal-title":"Science"},{"key":"key-10.3201\/eid1104.041167-201203200400-R31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nature02951","article-title":"Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.","volume":"431","author":"Kobasa","year":"2004","journal-title":"Nature"},{"key":"key-10.3201\/eid1104.041167-201203200400-R32","first-page":"589","article-title":"Laboratory and clinical characteristics of attenuated strains of influenza virus.","volume":"41","author":"Maassab","year":"1969","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid1104.041167-201203200400-R33","first-page":"1","article-title":"Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"52","author":"Harper","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1104.041167-201203200400-R34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0065-3527(03)61005-5","article-title":"West Nile virus: epidemiology and ecology in North America.","volume":"61","author":"Komar","year":"2003","journal-title":"Adv Virus Res"},{"key":"key-10.3201\/eid1104.041167-201203200400-R35","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1517\/14712598.4.8.1295","article-title":"West Nile virus vaccines.","volume":"4","author":"Hall","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"key-10.3201\/eid1104.041167-201203200400-R36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3201\/eid0704.010432","article-title":"Treatment of West Nile virus encephalitis with intravenous immunoglobulin.","volume":"7","author":"Shimoni","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1104.041167-201203200400-R37","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1242\/jeb.00602","article-title":"Trypsin-modulating oostatic factor: a potential new larvicide for mosquito control.","volume":"206","author":"Borovsky","year":"2003","journal-title":"J Exp Biol"},{"key":"key-10.3201\/eid1104.041167-201203200400-R38","unstructured":"National Institute of Allergy and Infectious Diseases. NIAID research on severe acute respiratory syndrome (SARS). [cited 2005 Feb 16]. Available from http:\/\/www.niaid.nih.gov\/factsheets\/sars.htm"},{"key":"key-10.3201\/eid1104.041167-201203200400-R39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"key":"key-10.3201\/eid1104.041167-201203200400-R40","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid1104.041167-201203200400-R41","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/S0140-6736(04)16501-X","article-title":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.","volume":"363","author":"Bukreyev","year":"2004","journal-title":"Lancet"},{"key":"key-10.3201\/eid1104.041167-201203200400-R42","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.","volume":"78","author":"Subbarao","year":"2004","journal-title":"J Virol"},{"key":"key-10.3201\/eid1104.041167-201203200400-R43","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat Med"},{"key":"key-10.3201\/eid1104.041167-201203200400-R44","unstructured":"National Institute of Allergy and Infectious Diseases. NIAID biodefense research. [cited 2005 Feb 16]. Available from http:\/\/www2.niaid.nih.gov\/biodefense\/"},{"key":"key-10.3201\/eid1104.041167-201203200400-R45","unstructured":"National Center for Biotechnology Information. Entrez Genome. [cited 2005 Feb 16]. Available from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=Genome"},{"key":"key-10.3201\/eid1104.041167-201203200400-R46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"key-10.3201\/eid1104.041167-201203200400-R47","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid1104.041167-201203200400-R48","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"key-10.3201\/eid1104.041167-201203200400-R49","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines.","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin Biol Ther"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/11\/4\/04-1167_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:02:41Z","timestamp":1732629761000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/11\/4\/04-1167_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,4]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1104.041167","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}